Page 42 - டெக்சாஸ் ஆரோக்கியம் அறிவியல் மையம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Cell therapy improves outcomes for heart failure patients, clinical trial shows A clinical trial conducted at the University of Louisville has shown for the first time that heart failure treatments using cells derived from the patient s own bone marrow and heart resulted in improved quality of life and reduced major adverse cardiac events for patients after one year. This is a very important advance in the field of cell therapy and in the management of heart failure. It suggests that a treatment, given only once, can produce long-term beneficial effects on the quality of life and prognosis of these patients. The results pave the way for a larger, Phase 3 trial of cell therapy in heart failure.

United statesRoberto bolliEmily hendersonIndiana universityCardiovascular cell therapy research networkTexas heart instituteUniversity of floridaSchool of public healthMinneapolis heart institute foundationUofl institute of molecular cardiologyUniversity of miamiStanford universityBlood instituteNational heartUniversity of louisvilleUofl institute